Alexandra Jouhanneaud

This inventor holds 12 USPTO granted patents and 7 published patent applications, plus 6 CIPO patents and 9 EPO patents. Top assignee: Pierre Fabre Medicament. Active years: 2012-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alexandra Jouhanneaud. Retrieved from https://idiyas.com/inventor/alexandra-jouhanneaud

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 12 (Patent Applications = 7)

% Patents Active = 50.0

CIPO Patents = 6 (Patent Applications = 2)

EPO Patents = 9 (Patent Applications = 18)

Average Co-Inventor Count = 1.9

ph-index = 3

Forward Citations = 26(Granted Patents)

Company Filing History:

12 out of 269

Pierre Fabre Medicament

patents

Years Active: 2012-2020

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10858423 - Composition for the treatment of IGF-1R expressing cancer (2020-12-08),

2. 10753937 - IGF-1R antibody and its use for the diagnosis of cancer (2020-08-25),

3. 10457734 - IGF-1R antibody and its use for the diagnosis of cancer (2019-10-29),

4. 9669106 - Conjugate of monomethyl auristatin F and trastuzumab and its use for the treatment of cancer (2017-06-06),

5. 9518120 - Anti-CXCR4 antibody and its use for the detection and diagnosis of cancer (2016-12-13),

6. 9388248 - Anti-CXCR4 antibodies and their use for the treatment of cancer (2016-07-12),

7. 9249223 - Humanized anti CXCR4 antibodies for the treatment of cancer (2016-02-02),

8. 9120852 - Antibody for the diagnosis and/or prognosis of cancer (2015-09-01),

9. 8808667 - Method for generating active antibodies against a resistance antigen, antibodies obtained by said method and their uses (2014-08-19),

10. 8673302 - Anti-cMet antibody and its use for the detection and the diagnosis of cancer (2014-03-18),

11. 8557964 - Anti CXCR4 antibodies and their use for the treatment of cancer (2013-10-15),

12. 8241646 - Method for generating active antibodies against a resistance antigen, antibodies obtained by said method and their uses (2012-08-14),

Title: Innovations by Alexandra Jouhanneaud

Introduction

Alexandra Jouhanneaud is a prominent inventor based in Bonneville, France. She has made significant contributions to the field of cancer treatment, holding a total of 12 patents. Her work focuses on innovative methods and compositions for treating cancers that express the IGF-1R receptor.

Latest Patents

Among her latest patents is a composition for the treatment of IGF-1R expressing cancer. This invention relates to a method for treating such cancers, as well as to compositions and kits designed for this treatment. One aspect of this invention involves the combined use of a first antibody to determine the IGF-1R status of a cancer and a second antibody used as an antibody-drug conjugate (ADC) for the treatment of the cancer. Another notable patent is related to IGF-1R antibodies characterized by specific CDR sequences, which are intended for use in detection methods of IGF-1R expressing tumoral cells.

Career Highlights

Throughout her career, Jouhanneaud has worked with notable companies, including Pierre Fabre Medicament. Her innovative approaches have positioned her as a key figure in the development of cancer therapies.

Collaborations

She has collaborated with esteemed colleagues such as Liliane Goetsch and Christine Klinguer-Hamour, contributing to the advancement of her research and inventions.

Conclusion

Alexandra Jouhanneaud's work exemplifies the impact of innovation in the medical field, particularly in cancer treatment. Her patents and collaborations highlight her dedication to improving patient outcomes through scientific advancements.

Profile summary based on public USPTO records.